Syndax stock maintains momentum as B.Riley reiterates Buy rating
Post Content
Business & Finance
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.
CDW shares rise 7% as Q4 earnings and revenue beat expectations
Post Content
Nuvation Bio stock maintains Buy rating at B.Riley on Ibtrozi sales momentum
Post Content
Cognizant forecasts annual revenue above estimates on strong AI demand
Post Content
Refiner Phillips 66 beats quarterly profit estimates as margins rebound
Post Content
GSK Q4 2025 slides presentation: Specialty medicines drive earnings beat
Post Content
Wegovy-maker Novo Nordisk warns ’unprecedented’ price pressure to hit sales
Post Content
First Guaranty Bancshares Inc earnings beat by $0.41, revenue topped estimates
Post Content
GE HealthCare forecasts 2026 profit above estimates on strong demand for medical devices
Post Content
Investors were braced for an AI fallout — just not this one, popular strategist says.
Nomura’s Charlie McElligott says second-order AI disruption worries have arrived early. Investors need to get ready.